front page arrow Cannabis News arrow Australia arrow Lithium could treat cannabis withdrawal: study
Lithium could treat cannabis withdrawal: study
A new study has found that lithium carbonate may help long-term cannabis users quit the drug.
The preliminary study showed short-term use of lithium significantly reduced depression, anxiety and other cannabis withdrawal symptoms.

Chief investigator Dr Adam Winstock says while a larger trial will be needed to confirm the findings, the early results are promising.
 Image

"There are a significant proportion of heavy cannabis users who do experience withdrawal," he said.

"At least in the very small, uncontrolled trial, lithium may have the potential to alleviate the discomfort associated with that withdrawal and that's important because it actually might help people quit."

Lithium carbonate has been previously been shown to be help in the treatment of symptoms from cannabis withdrawal.

Dr Winstock says if a follow-up trial confirms the results, it will be one of the first studies to show medication can be used to help treat the symptoms of cannabis withdrawal.

"We hope this preliminary work will lead to a larger scale, multi-site, placebo-controlled study next year," he said.

"Given that cannabis is the most widely-used illicit drug in the world - and about one in 10 users become dependent on it - the possibility of finding an effective treatment to manage withdrawal is exciting."

Image

Twenty regular cannabis users took part in the seven-day program, which involved taking a dose of lithium carbonate daily.

Of those participants, 29 per cent did not use marijuana at all in that time.

 http://www.abc.net.au 
Trackback(0)
Comments (1)Add Comment
Psychopharmacotherapy
written by PapaKelt, March 08, 2008
I find this interesting in terms of adding to the toolkit of available interventions for the treatment of cannabis dependency, although I would think that more research, especially in terms of intervening in terms of polydrug use, or particular ?problem? groups such as pregnant females or dual diagnosis (comorbidity) Beyond this I find the current popularity of psychopharmacotherapy in the AOD treatment field interesting as I see it as symptomatic of the same sort of pharmacologically determinist thinking that is productive of addictions.

Reminds me of the film Withnail and I ? why trust one drug and not another? That?s just politics. Maybe it?s the lithium, given its fairly heavy duty reputation as an antidepressant of last resort. Saying it reduces depression strikes me as rather like saying that patients who had been administered a large dose of Thorazine displayed reduced anxiety.

Regards,

PapaKelt

Write comment
You must be logged in to a comment. Please register if you do not have an account yet.

busy
 
< Prev   Next >

Cannabis Search Portal

Google

Login Form






Lost Password?
No account yet? Register
Visitors: 821620

Alexa Site Stats